Pay in 4 interest-free payments of $7.48 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
GLP-1 agonists may be preferable in some elderly patients due to lower hypoglycemia risk, though GI side effects and potential for weight loss (which can be undesirable in frail elderly patients) require careful consideration
General procedure and design This study used a within-subject design including screening, and two baseline assessments before treatment initiation (pretreatment), and one assessment at posttreatment
Glucose-induced glucagon-like Peptide 1 secretion is deficient in patients with non-alcoholic fatty liver disease
This is an observational study, not a randomised trial, and the authors caution against basing treatment recommendations on these data, without further confirmation
Avoid direct forceful injection onto the peptide powder
Side effects: what the FDA labels actually list Both pills are GLP-1s, so most of what youll feel is the same either way, and its mostly your gut
